Results 231 to 240 of about 364,087 (292)
When Hyperthyroidism Slows the Heart: Graves' Disease Complicated by a High-Grade Atrioventricular Block. [PDF]
Ramdath MM, Teelucksingh JD.
europepmc +1 more source
Evans' Syndrome Associated with Graves' Disease.
Miho YASHIRO +9 more
openalex +2 more sources
T cell membrane‐coated MgCO3/Fe‐CD nanozyme loaded with TEPP‐46 (TFMP) enhances breast cancer radioimmunotherapy by reprogramming mitochondrial metabolism in T cells and tumors. It targets PD‐L1, converts H2O2 into ROS, neutralizes acidity, and releases Mg2⁺/TEPP‐46 to boost T cell activation.
Hanyu Zhang +7 more
wiley +1 more source
Cancer cells drive adjacent adipose tissue to release fatty acids by secreting CCL2, which activates PPARα‐dependent lipolysis. The resulting fatty acid influx amplifies HIF‐1α/CCL2 signaling, establishing a positive feedback loop that fuels tumor growth.
Jeong‐Eun Yun +9 more
wiley +1 more source
Preoperative serum lipids as novel predictors for concomitant thyroid carcinoma in Graves' disease. [PDF]
Gao X, Liu M, Wu Y.
europepmc +1 more source
The Irish School of Medicine: Graves, Stokes and Corrigan [PDF]
Walsh, James J.
core +1 more source
Combined electro-thymo-lysate therapy for Graves' disease and hyperthyroidism
I. D. Kudenko
openalex +1 more source
This study examines the mechanism by which alfalfa saponin (AS) regulates intestinal stemness via modulation of the gut microbiota. The results indicate that AS significantly increases the abundance of Lactobacillus intestinalis, which subsequently activates Wnt signaling via bile acid metabolism and enhances intestinal stemness. These findings provide
Mengqi Liu +8 more
wiley +1 more source
Remission of Graves' Disease Through Lifestyle Interventions. [PDF]
Sharma P.
europepmc +1 more source

